Gefitinib Tablets Market, Global Outlook and Forecast 2023-2029

Report ID: MMG299754 | Category: Pharma & Healthcare | Pages: 111 | Format: PDF | Published Date: December 08,2023

Request Sample Enquiry before buying Ask For Discount

Single User-$3250.00 Multi User-$4225.00

Report Description
View Table of Contents

Report Summary

The global Gefitinib Tablets market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Original Drugs Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Gefitinib Tablets include Qilu Pharmaceutical, Sichuan Kelun Pharmaceutical Co.,Ltd., Jiangsu Hengrui Pharmaceuticals Co.,ltd., Jiangsu Chia Tai-Tianqing Pharmaceutical Co., Ltd., Yangtze River Pharmaceutical (Group) Co., Ltd., Jiangsu Tasly Diyi Pharmaceutical Co., Ltd., Shanghai DESANO Pharmaceuticals Holding Co., Ltd., NatcoPharma and AstraZeneca plc, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
This report aims to provide a comprehensive presentation of the global market for Gefitinib Tablets, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gefitinib Tablets. This report contains market size and forecasts of Gefitinib Tablets in global, including the following market information:
Global Gefitinib Tablets Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Gefitinib Tablets Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Gefitinib Tablets companies in 2022 (%)
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Gefitinib Tablets manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Gefitinib Tablets Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Gefitinib Tablets Market Segment Percentages, by Type, 2022 (%)
    Original Drugs
    Generic Drugs
Global Gefitinib Tablets Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Gefitinib Tablets Market Segment Percentages, by Application, 2022 (%)
    Breast Cancer
    Lung Cancer
    Other
Global Gefitinib Tablets Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Gefitinib Tablets Market Segment Percentages, By Region and Country, 2022 (%)
    North America
        US
        Canada
        Mexico
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
        Nordic Countries
        Benelux
        Rest of Europe
    Asia
        China
        Japan
        South Korea
        Southeast Asia
        India
        Rest of Asia
    South America
        Brazil
        Argentina
        Rest of South America
    Middle East & Africa
        Turkey
        Israel
        Saudi Arabia
        UAE
        Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Gefitinib Tablets revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Gefitinib Tablets revenues share in global market, 2022 (%)
Key companies Gefitinib Tablets sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Gefitinib Tablets sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
    Qilu Pharmaceutical
    Sichuan Kelun Pharmaceutical Co.,Ltd.
    Jiangsu Hengrui Pharmaceuticals Co.,ltd.
    Jiangsu Chia Tai-Tianqing Pharmaceutical Co., Ltd.
    Yangtze River Pharmaceutical (Group) Co., Ltd.
    Jiangsu Tasly Diyi Pharmaceutical Co., Ltd.
    Shanghai DESANO Pharmaceuticals Holding Co., Ltd.
    NatcoPharma
    AstraZeneca plc
    Intelicure Lifesciences
    Weefsel Pharma
    Taj Pharmaceuticals
    Saintroy Lifescience
    Actiza Pharmaceutical
    Teva
Outline of Major Chapters:
Chapter 1: Introduces the definition of Gefitinib Tablets, market overview.
Chapter 2: Global Gefitinib Tablets market size in revenue and volume.
Chapter 3: Detailed analysis of Gefitinib Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Gefitinib Tablets in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Gefitinib Tablets capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

1 Introduction to Research & Analysis Reports
    1.1 Gefitinib Tablets Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Gefitinib Tablets Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Gefitinib Tablets Overall Market Size
    2.1 Global Gefitinib Tablets Market Size: 2022 VS 2029
    2.2 Global Gefitinib Tablets Revenue, Prospects & Forecasts: 2018-2029
    2.3 Global Gefitinib Tablets Sales: 2018-2029
3 Company Landscape
    3.1 Top Gefitinib Tablets Players in Global Market
    3.2 Top Global Gefitinib Tablets Companies Ranked by Revenue
    3.3 Global Gefitinib Tablets Revenue by Companies
    3.4 Global Gefitinib Tablets Sales by Companies
    3.5 Global Gefitinib Tablets Price by Manufacturer (2018-2023)
    3.6 Top 3 and Top 5 Gefitinib Tablets Companies in Global Market, by Revenue in 2022
    3.7 Global Manufacturers Gefitinib Tablets Product Type
    3.8 Tier 1, Tier 2 and Tier 3 Gefitinib Tablets Players in Global Market
        3.8.1 List of Global Tier 1 Gefitinib Tablets Companies
        3.8.2 List of Global Tier 2 and Tier 3 Gefitinib Tablets Companies
4 Sights by Product
    4.1 Overview
        4.1.1 By Type - Global Gefitinib Tablets Market Size Markets, 2022 & 2029
        4.1.2 Original Drugs
        4.1.3 Generic Drugs
    4.2 By Type - Global Gefitinib Tablets Revenue & Forecasts
        4.2.1 By Type - Global Gefitinib Tablets Revenue, 2018-2023
        4.2.2 By Type - Global Gefitinib Tablets Revenue, 2024-2029
        4.2.3 By Type - Global Gefitinib Tablets Revenue Market Share, 2018-2029
    4.3 By Type - Global Gefitinib Tablets Sales & Forecasts
        4.3.1 By Type - Global Gefitinib Tablets Sales, 2018-2023
        4.3.2 By Type - Global Gefitinib Tablets Sales, 2024-2029
        4.3.3 By Type - Global Gefitinib Tablets Sales Market Share, 2018-2029
    4.4 By Type - Global Gefitinib Tablets Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Gefitinib Tablets Market Size, 2022 & 2029
        5.1.2 Breast Cancer
        5.1.3 Lung Cancer
        5.1.4 Other
    5.2 By Application - Global Gefitinib Tablets Revenue & Forecasts
        5.2.1 By Application - Global Gefitinib Tablets Revenue, 2018-2023
        5.2.2 By Application - Global Gefitinib Tablets Revenue, 2024-2029
        5.2.3 By Application - Global Gefitinib Tablets Revenue Market Share, 2018-2029
    5.3 By Application - Global Gefitinib Tablets Sales & Forecasts
        5.3.1 By Application - Global Gefitinib Tablets Sales, 2018-2023
        5.3.2 By Application - Global Gefitinib Tablets Sales, 2024-2029
        5.3.3 By Application - Global Gefitinib Tablets Sales Market Share, 2018-2029
    5.4 By Application - Global Gefitinib Tablets Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
    6.1 By Region - Global Gefitinib Tablets Market Size, 2022 & 2029
    6.2 By Region - Global Gefitinib Tablets Revenue & Forecasts
        6.2.1 By Region - Global Gefitinib Tablets Revenue, 2018-2023
        6.2.2 By Region - Global Gefitinib Tablets Revenue, 2024-2029
        6.2.3 By Region - Global Gefitinib Tablets Revenue Market Share, 2018-2029
    6.3 By Region - Global Gefitinib Tablets Sales & Forecasts
        6.3.1 By Region - Global Gefitinib Tablets Sales, 2018-2023
        6.3.2 By Region - Global Gefitinib Tablets Sales, 2024-2029
        6.3.3 By Region - Global Gefitinib Tablets Sales Market Share, 2018-2029
    6.4 North America
        6.4.1 By Country - North America Gefitinib Tablets Revenue, 2018-2029
        6.4.2 By Country - North America Gefitinib Tablets Sales, 2018-2029
        6.4.3 US Gefitinib Tablets Market Size, 2018-2029
        6.4.4 Canada Gefitinib Tablets Market Size, 2018-2029
        6.4.5 Mexico Gefitinib Tablets Market Size, 2018-2029
    6.5 Europe
        6.5.1 By Country - Europe Gefitinib Tablets Revenue, 2018-2029
        6.5.2 By Country - Europe Gefitinib Tablets Sales, 2018-2029
        6.5.3 Germany Gefitinib Tablets Market Size, 2018-2029
        6.5.4 France Gefitinib Tablets Market Size, 2018-2029
        6.5.5 U.K. Gefitinib Tablets Market Size, 2018-2029
        6.5.6 Italy Gefitinib Tablets Market Size, 2018-2029
        6.5.7 Russia Gefitinib Tablets Market Size, 2018-2029
        6.5.8 Nordic Countries Gefitinib Tablets Market Size, 2018-2029
        6.5.9 Benelux Gefitinib Tablets Market Size, 2018-2029
    6.6 Asia
        6.6.1 By Region - Asia Gefitinib Tablets Revenue, 2018-2029
        6.6.2 By Region - Asia Gefitinib Tablets Sales, 2018-2029
        6.6.3 China Gefitinib Tablets Market Size, 2018-2029
        6.6.4 Japan Gefitinib Tablets Market Size, 2018-2029
        6.6.5 South Korea Gefitinib Tablets Market Size, 2018-2029
        6.6.6 Southeast Asia Gefitinib Tablets Market Size, 2018-2029
        6.6.7 India Gefitinib Tablets Market Size, 2018-2029
    6.7 South America
        6.7.1 By Country - South America Gefitinib Tablets Revenue, 2018-2029
        6.7.2 By Country - South America Gefitinib Tablets Sales, 2018-2029
        6.7.3 Brazil Gefitinib Tablets Market Size, 2018-2029
        6.7.4 Argentina Gefitinib Tablets Market Size, 2018-2029
    6.8 Middle East & Africa
        6.8.1 By Country - Middle East & Africa Gefitinib Tablets Revenue, 2018-2029
        6.8.2 By Country - Middle East & Africa Gefitinib Tablets Sales, 2018-2029
        6.8.3 Turkey Gefitinib Tablets Market Size, 2018-2029
        6.8.4 Israel Gefitinib Tablets Market Size, 2018-2029
        6.8.5 Saudi Arabia Gefitinib Tablets Market Size, 2018-2029
        6.8.6 UAE Gefitinib Tablets Market Size, 2018-2029
7 Manufacturers & Brands Profiles
    7.1 Qilu Pharmaceutical
        7.1.1 Qilu Pharmaceutical Company Summary
        7.1.2 Qilu Pharmaceutical Business Overview
        7.1.3 Qilu Pharmaceutical Gefitinib Tablets Major Product Offerings
        7.1.4 Qilu Pharmaceutical Gefitinib Tablets Sales and Revenue in Global (2018-2023)
        7.1.5 Qilu Pharmaceutical Key News & Latest Developments
    7.2 Sichuan Kelun Pharmaceutical Co.,Ltd.
        7.2.1 Sichuan Kelun Pharmaceutical Co.,Ltd. Company Summary
        7.2.2 Sichuan Kelun Pharmaceutical Co.,Ltd. Business Overview
        7.2.3 Sichuan Kelun Pharmaceutical Co.,Ltd. Gefitinib Tablets Major Product Offerings
        7.2.4 Sichuan Kelun Pharmaceutical Co.,Ltd. Gefitinib Tablets Sales and Revenue in Global (2018-2023)
        7.2.5 Sichuan Kelun Pharmaceutical Co.,Ltd. Key News & Latest Developments
    7.3 Jiangsu Hengrui Pharmaceuticals Co.,ltd.
        7.3.1 Jiangsu Hengrui Pharmaceuticals Co.,ltd. Company Summary
        7.3.2 Jiangsu Hengrui Pharmaceuticals Co.,ltd. Business Overview
        7.3.3 Jiangsu Hengrui Pharmaceuticals Co.,ltd. Gefitinib Tablets Major Product Offerings
        7.3.4 Jiangsu Hengrui Pharmaceuticals Co.,ltd. Gefitinib Tablets Sales and Revenue in Global (2018-2023)
        7.3.5 Jiangsu Hengrui Pharmaceuticals Co.,ltd. Key News & Latest Developments
    7.4 Jiangsu Chia Tai-Tianqing Pharmaceutical Co., Ltd.
        7.4.1 Jiangsu Chia Tai-Tianqing Pharmaceutical Co., Ltd. Company Summary
        7.4.2 Jiangsu Chia Tai-Tianqing Pharmaceutical Co., Ltd. Business Overview
        7.4.3 Jiangsu Chia Tai-Tianqing Pharmaceutical Co., Ltd. Gefitinib Tablets Major Product Offerings
        7.4.4 Jiangsu Chia Tai-Tianqing Pharmaceutical Co., Ltd. Gefitinib Tablets Sales and Revenue in Global (2018-2023)
        7.4.5 Jiangsu Chia Tai-Tianqing Pharmaceutical Co., Ltd. Key News & Latest Developments
    7.5 Yangtze River Pharmaceutical (Group) Co., Ltd.
        7.5.1 Yangtze River Pharmaceutical (Group) Co., Ltd. Company Summary
        7.5.2 Yangtze River Pharmaceutical (Group) Co., Ltd. Business Overview
        7.5.3 Yangtze River Pharmaceutical (Group) Co., Ltd. Gefitinib Tablets Major Product Offerings
        7.5.4 Yangtze River Pharmaceutical (Group) Co., Ltd. Gefitinib Tablets Sales and Revenue in Global (2018-2023)
        7.5.5 Yangtze River Pharmaceutical (Group) Co., Ltd. Key News & Latest Developments
    7.6 Jiangsu Tasly Diyi Pharmaceutical Co., Ltd.
        7.6.1 Jiangsu Tasly Diyi Pharmaceutical Co., Ltd. Company Summary
        7.6.2 Jiangsu Tasly Diyi Pharmaceutical Co., Ltd. Business Overview
        7.6.3 Jiangsu Tasly Diyi Pharmaceutical Co., Ltd. Gefitinib Tablets Major Product Offerings
        7.6.4 Jiangsu Tasly Diyi Pharmaceutical Co., Ltd. Gefitinib Tablets Sales and Revenue in Global (2018-2023)
        7.6.5 Jiangsu Tasly Diyi Pharmaceutical Co., Ltd. Key News & Latest Developments
    7.7 Shanghai DESANO Pharmaceuticals Holding Co., Ltd.
        7.7.1 Shanghai DESANO Pharmaceuticals Holding Co., Ltd. Company Summary
        7.7.2 Shanghai DESANO Pharmaceuticals Holding Co., Ltd. Business Overview
        7.7.3 Shanghai DESANO Pharmaceuticals Holding Co., Ltd. Gefitinib Tablets Major Product Offerings
        7.7.4 Shanghai DESANO Pharmaceuticals Holding Co., Ltd. Gefitinib Tablets Sales and Revenue in Global (2018-2023)
        7.7.5 Shanghai DESANO Pharmaceuticals Holding Co., Ltd. Key News & Latest Developments
    7.8 NatcoPharma
        7.8.1 NatcoPharma Company Summary
        7.8.2 NatcoPharma Business Overview
        7.8.3 NatcoPharma Gefitinib Tablets Major Product Offerings
        7.8.4 NatcoPharma Gefitinib Tablets Sales and Revenue in Global (2018-2023)
        7.8.5 NatcoPharma Key News & Latest Developments
    7.9 AstraZeneca plc
        7.9.1 AstraZeneca plc Company Summary
        7.9.2 AstraZeneca plc Business Overview
        7.9.3 AstraZeneca plc Gefitinib Tablets Major Product Offerings
        7.9.4 AstraZeneca plc Gefitinib Tablets Sales and Revenue in Global (2018-2023)
        7.9.5 AstraZeneca plc Key News & Latest Developments
    7.10 Intelicure Lifesciences
        7.10.1 Intelicure Lifesciences Company Summary
        7.10.2 Intelicure Lifesciences Business Overview
        7.10.3 Intelicure Lifesciences Gefitinib Tablets Major Product Offerings
        7.10.4 Intelicure Lifesciences Gefitinib Tablets Sales and Revenue in Global (2018-2023)
        7.10.5 Intelicure Lifesciences Key News & Latest Developments
    7.11 Weefsel Pharma
        7.11.1 Weefsel Pharma Company Summary
        7.11.2 Weefsel Pharma Gefitinib Tablets Business Overview
        7.11.3 Weefsel Pharma Gefitinib Tablets Major Product Offerings
        7.11.4 Weefsel Pharma Gefitinib Tablets Sales and Revenue in Global (2018-2023)
        7.11.5 Weefsel Pharma Key News & Latest Developments
    7.12 Taj Pharmaceuticals
        7.12.1 Taj Pharmaceuticals Company Summary
        7.12.2 Taj Pharmaceuticals Gefitinib Tablets Business Overview
        7.12.3 Taj Pharmaceuticals Gefitinib Tablets Major Product Offerings
        7.12.4 Taj Pharmaceuticals Gefitinib Tablets Sales and Revenue in Global (2018-2023)
        7.12.5 Taj Pharmaceuticals Key News & Latest Developments
    7.13 Saintroy Lifescience
        7.13.1 Saintroy Lifescience Company Summary
        7.13.2 Saintroy Lifescience Gefitinib Tablets Business Overview
        7.13.3 Saintroy Lifescience Gefitinib Tablets Major Product Offerings
        7.13.4 Saintroy Lifescience Gefitinib Tablets Sales and Revenue in Global (2018-2023)
        7.13.5 Saintroy Lifescience Key News & Latest Developments
    7.14 Actiza Pharmaceutical
        7.14.1 Actiza Pharmaceutical Company Summary
        7.14.2 Actiza Pharmaceutical Business Overview
        7.14.3 Actiza Pharmaceutical Gefitinib Tablets Major Product Offerings
        7.14.4 Actiza Pharmaceutical Gefitinib Tablets Sales and Revenue in Global (2018-2023)
        7.14.5 Actiza Pharmaceutical Key News & Latest Developments
    7.15 Teva
        7.15.1 Teva Company Summary
        7.15.2 Teva Business Overview
        7.15.3 Teva Gefitinib Tablets Major Product Offerings
        7.15.4 Teva Gefitinib Tablets Sales and Revenue in Global (2018-2023)
        7.15.5 Teva Key News & Latest Developments
8 Global Gefitinib Tablets Production Capacity, Analysis
    8.1 Global Gefitinib Tablets Production Capacity, 2018-2029
    8.2 Gefitinib Tablets Production Capacity of Key Manufacturers in Global Market
    8.3 Global Gefitinib Tablets Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
    9.1 Market Opportunities & Trends
    9.2 Market Drivers
    9.3 Market Restraints
10 Gefitinib Tablets Supply Chain Analysis
    10.1 Gefitinib Tablets Industry Value Chain
    10.2 Gefitinib Tablets Upstream Market
    10.3 Gefitinib Tablets Downstream and Clients
    10.4 Marketing Channels Analysis
        10.4.1 Marketing Channels
        10.4.2 Gefitinib Tablets Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
    12.1 Note
    12.2 Examples of Clients
    12.3 Disclaimer

FAQ's

What does the report cover (Scope)?

It contains all the geographic trends, and market analysis for global market

ENTER REPORT NAME TO SEARCH

Gefitinib Tablets Market, Global Outlook and Forecast 2023-2029

Report Summary

Table of Contents

FAQ's

What does the report cover (Scope)?